veterinary ultrasound

veterinary vaccines

Manhattan Pharmaceuticals Inc. to Present at the Rodman + Renshaw Techvest Global Healthcare Conference

pharmaceuticals scrubs

CEST (3:05 AM EDT) Wednesday, May 4th, at the
Intercontinental Hotel in Paris.

veterinary microchip

This press release shall not constitute an offer to sell or the
solicitation of an offer to buy nor shall there be any sale of these
securities in any state in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the securities laws of
any such state.

identify owns

com.
THESE STATEMENTS ARE BASED ON OUR CURRENT BELIEFS AND EXPECTATIONS AS
TO SUCH FUTURE OUTCOMES.
33rd Street, New York NY 10001 (646) 733-4166.

Licensed veterinarians require a range of supplies and products, including vaccines, software and drugs.

scrubs homoeopathic

The presentation will be webcast live and archived online on the
Investor Relations section of Manhattan's website at
www.com/),
a development stage pharmaceutical company , acquires and develops
proprietary prescription drugs for large, underserved patient
populations .

MWI Veterinary Supply Announces Pricing of Initial Public Offering

is a leading distributor of animal health
products to veterinarians across the United States. The products MWI sells include pharmaceuticals, vaccines,
parasiticides, diagnostics, capital equipment, supplies, veterinary pet food
and nutritional products.

recruiter vet

M.

About MWI Veterinary Supply, Inc.

tenders healthcare

identify microchip

manhattanpharma.

pharmaceuticals biopharmaceuticals

CERTAIN STATEMENTS CONTAINED IN THIS NEWS RELEASE THAT ARE
FORWARD-LOOKING IN NATURE ARE BASED ON THE CURRENT BELIEFS AND
ASSUMPTIONS OF OUR MANAGEMENT. The offering of these securities will be made only by means
of a prospectus, copies of which may be obtained by contacting Banc of America
Securities LLC, Capital Markets Operations (Prospectus Fulfillment), 100 W.

vaccines healthcare

Business Editors /Health Editors
Rodman + Renshaw Techvest Global Healthcare Conference 2005

NEW YORK-- --Manhattan
Pharmaceuticals, Inc. (http://www.manhattanpharma. THESE STATEMENTS ARE SUBJECT TO
KNOWN AND UNKNOWN RISKS AND UNCERTAINTIES THAT MAY CAUSE ACTUAL FUTURE
EXPERIENCE AND RESULTS TO DIFFER MATERIALLY FROM THE STATEMENTS MADE. The shares have been listed on the Nasdaq
National Market under the symbol "MWIV.

veterinary pharmaceuticals

00 per share.

veterinarians vet

About Manhattan Pharmaceuticals, Inc. To meet the needs of other major, under served
medical markets while lowering development risks, Manhattan
Pharmaceuticals also developing PTH (1-34), a peptide believed to be a
regulator of epidermal cell growth, under development for psoriasis
and other dermatological conditions and Propofol Lingual Spray, a
convenient , proprietary lingual spray formulation of propofol, the
world's best-selling general anesthetic, as a sedative-hypnotic for
use during diagnostic and therapeutic procedures.

veterinarians identify

WHEN USED IN THIS PRESS RELEASE, THE
WORDS "MAY," "COULD," "SHOULD," "ANTICIPATE," "BELIEVE," "ESTIMATE,"
"EXPECT," "INTEND ," "PLAN," "PREDICT," AND SIMILAR EXPRESSIONS AND
THEIR VARIANTS MAY BE USED TO IDENTIFY FORWARD-LOOKING STATEMENTS. MWI distributes more than
10,000 products from over 350 vendors to more than 14,000 veterinary practices
nationwide.

vet vca

Manhattan is one of 160 public and
private emerging growth biotechnology companies scheduled to present
at the conference. An audio replay of the presentation will also
be available for 90 days after the conference. DRUG DISCOVERY AND DEVELOPMENT INVOLVE A HIGH
DEGREE OF RISK. (Nasdaq: MWIV) announced today the pricing of an initial public offering
of 4,333,334 shares of its common stock, all of which were offered by the
Company, at $ 17.

homoeopathic microchip

("Manhattan " OTCBB: MHTT), has accepted an
invitation to speak at the Rodman + Renshaw Techvest Global Healthcare
Conference at 9:05 A." Banc of America Securities LLC
served as the book running manager and William Blair + Company, LLC and Piper
Jaffray + Co. acted as co-managers for the offering.

pharmaceuticals vet

Manhattan Pharmaceuticals, Inc. In view of the worldwide obesity epidemic, the Company is
developing Oleoyl estrone, an orally administered novel therapeutic
for weight loss.

tenders veterinarians

recruiter healthcare

SUCH STATEMENTS ARE VALID ONLY AS OF TODAY, AND WE DISCLAIM ANY
OBLIGATION TO UPDATE THIS INFORMATION.

isopathic recruiter

Doug Abel, President and CEO of Manhattan Pharmaceuticals, will
provide a company overview, an update on its current clinical
development programs and recent acquisition of Tarpan Therapeutics.

owns veterinarians

scrubs biopharmaceuticals

veterinary homoeopathic

:
MWI Veterinary Supply , Inc.

homoeopathic recruiter

FACTORS THAT MIGHT CAUSE SUCH A MATERIAL DIFFERENCE
INCLUDE, AMONG OTHERS, UNCERTAINTIES RELATED TO THE ABILITY TO ATTRACT
AND RETAIN PARTNERS FOR OUR TECHNOLOGIES, THE IDENTIFICATION OF LEAD
COMPOUNDS , THE SUCCESSFUL PRECLINICAL DEVELOPMENT THEREOF, THE
COMPLETION OF CLINICAL TRIALS, THE FDA REVIEW PROCESS AND OTHER
GOVERNMENTAL REGULATION, OUR PHARMACEUTICAL COLLABORATOR'S ABILITY TO
SUCCESSFULLY DEVELOP AND COMMERCIALIZE DRUG CANDIDATES, COMPETITION
FROM OTHER PHARMACEUTICAL COMPANIES, PRODUCT PRICING AND THIRD PARTY
REIMBURSEMENT, AND OTHER FACTORS DESCRIBED IN OUR FILINGS WITH THE
SECURITIES AND EXCHANGE COMMISSION. MERIDIAN, Idaho, MWI Veterinary Supply,
Inc. MWI Veterinary Supply
has agreed to sell up to an additional 650,000 shares of common stock to the
underwriters to cover over-allotments, if any.